Skip to main content

Loading bill details...

Initial load may take a moment while we fetch the latest data

HR. 9635: To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes. | CIV.IQ